PharmaCyte Biotech (PMCB) Debt to Equity (2010 - 2026)
PharmaCyte Biotech (PMCB) debt to equity from Apr 30, 2010 to Jan 31, 2026. The current PharmaCyte Biotech (PMCB) debt to equity is 0.00%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Annual Debt to Equity change of PharmaCyte Biotech (PMCB)
| Year | Debt to Equity | Change |
|---|---|---|
| 2026 | 0.00% | N/A |
| 2025 | 0.00% | N/A |
| 2024 | 0.00% | N/A |
| 2023 | 0.00% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | -100.00% |
| 2011 | -99.58% | N/A |
| 2010 | 0.00% | N/A |